Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Impact Biomedical Inc. (IBO) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.02M |
|
$-1.47M |
|
$0.00M |
|
$0.02M |
|
$0.97M |
|
$-0.95M |
|
$-0.53M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-0.95M |
|
$-0.66M |
|
12.19M |
|
12.19M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$0.92M |
|
$0.01M |
|
$17.29M |
|
$18.21M |
|
$23.79M |
|
-- |
|
$3.27M |
|
$27.06M |
|
$-8.91M |
|
$-26.13M |
|
$-8.85M |
|
12.19M |
|
| Cash Flow Statement Financials | |
$-1.99M |
|
$0.00M |
|
$0.00M |
|
$2.00M |
|
$0.01M |
|
$-1.99M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-2.58 |
|
94.44% |
|
-5266.67% |
|
-5266.67% |
|
-- |
|
-8194.44% |
|
-8166.67% |
|
$-1.99M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
1.20 |
|
75.00 |
|
16.55% |
|
5.64% |
|
-8.10% |
|
16.66% |
|
$-0.73 |
|
$-0.16 |
|
$-0.16 |
|